Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Encinitas CA, La Jolla CA, San Diego CA, Surprise AZ,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase2, Recruiting
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
for
Single-ventricle, Stenosis
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 12 - 21
Code: NCT07073612
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
for
Agitation Associated With Alzheimer's Dementia
Location: Anaheim CA, Las Vegas NV, Tampa FL, Brandon FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06651567
Phase2, Recruiting
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Upland CA, Duarte CA, Torrance CA, Arcadia CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 40+
Code: NCT06954831
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Los Angeles CA, Portland OR, Missoula MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Fullerton CA, Los Angeles CA, Portland OR,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Huntington Beach CA, Laguna Niguel CA, La Palma CA,
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: Duarte CA, Rochester NY, Richmond VA, New Haven CT,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Newport Beach CA, Los Angeles CA, Chandler AZ, Reno NV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial